Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)

Not yet recruiting

Phase 1/2 Results N/A

References

Sources for Trial Information